Department of Biomedical Engineering, Stevens Institute of Technology, Hoboken, New Jersey 07302, United States.
Department of Biomedical Engineering, Columbia University, New York, New York 10032, United States.
ACS Biomater Sci Eng. 2022 Jan 10;8(1):82-88. doi: 10.1021/acsbiomaterials.1c01031. Epub 2021 Dec 7.
Injured or diseased airway epithelium due to repeated environmental insults or genetic mutations can lead to a functional decline of the lung and incurable lung diseases. Bioengineered airway tissue constructs can facilitate investigation of human lung diseases and accelerate the development of effective therapeutics. Here, we report robust tissue manipulation modalities that allow: (i) selective removal of the endogenous epithelium of cultured airway tissues and (ii) spatially uniform distribution and prolonged cultivation of exogenous cells that are implanted topically onto the denuded airway lumen. Results obtained highlight that our approach to airway tissue manipulation can facilitate controlled removal of the airway epithelium and subsequent homogeneous distribution of newly implanted cells. This study can contribute to the creation of innovative tissue engineering methodologies that can facilitate the treatment of lung diseases, such as cystic fibrosis, primary ciliary dyskinesia, and chronic obstructive pulmonary disease.
由于反复的环境损伤或基因突变,受损或患病的气道上皮细胞可导致肺部功能下降和不可治愈的肺部疾病。生物工程气道组织构建体可以促进人类肺部疾病的研究,并加速有效治疗方法的开发。在这里,我们报告了强大的组织操作方式,允许:(i)选择性去除培养气道组织的内源性上皮细胞,以及(ii)将外源性细胞均匀分布并延长培养,将其局部植入裸露的气道腔。结果表明,我们的气道组织操作方法可以促进气道上皮细胞的受控去除,以及随后新植入细胞的均匀分布。这项研究可以为创新的组织工程方法的创建做出贡献,这些方法可以促进囊性纤维化、原发性纤毛运动障碍和慢性阻塞性肺疾病等肺部疾病的治疗。